Therapeutic compounds and related methods of use
US9073890B2 · kind B2 · utility
9Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 30, 2010 |
| Grant date | Jul 7, 2015 |
| Priority date | — |
| Expiry date | Jan 23, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds, pharmaceutical compositions containing the compounds, and methods of using the compounds to treat a disorder, e.g., schizophrenia and cognitive deficit, in a subject are described herein. The compounds disclosed herein include quinoline and quinazoline-containing compounds that modulate striatal-enriched tyrosine phosphatase (STEP) activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.